novo nordisk semaglutide nash MASH Management and Information Wegovy Gets Green Light for

Imaging of changes in copper trafficking and redistribution in a mouse model of Niemann-pick C disease using positron emission tomography

A few people may get infections more easily or develop headaches when using GLP-1 agonists

[28] Ask your doctor if you qualify for the cardiovascular indication If you have sleep apnea, ask about Zepbound insteadit has FDA approval for that condition Some states cover Wegovy for MACE even when they exclude obesity Explore Patient Assistance Programs Novo Nordisk offers patient assistance for qualifying individuals: Important: Wegovy is NOT covered by Novo Nordisk's Patient Assistance Program (PAP)

Plasmacytoid dendritic cells produce excessive type I interferons, driving a cascade of immune activation

Wegovy and tirzepatide are approved for weight loss in people who do not have diabetes

Contact your healthcare provider within 24 hours for persistent neurological symptoms like numbness, vision changes, or severe headaches that may require evaluation